GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ALDH1A1 | 402 | LTM | Small Cell Lung Cancer | Carcinoma | H2227 | Cisplatin | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.684 | 33969609
|
ALDH1A1 | 402 | LTM | Small Cell Lung Cancer | Carcinoma | H2227 | Etopside | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.684 | 33969609
|
KLF4 | 6348 | LTM | Small Cell Lung Cancer | Carcinoma | H2227 | Cisplatin | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0891 | 33969609
|
KLF4 | 6348 | LTM | Small Cell Lung Cancer | Carcinoma | H2227 | Etopside | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0891 | 33969609
|
POU5F1 | 9221 | LTM | Small Cell Lung Cancer | Carcinoma | H2227 | Cisplatin | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 33969609
|
POU5F1 | 9221 | LTM | Small Cell Lung Cancer | Carcinoma | H2227 | Etopside | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 33969609
|